Parkinson disease is the second most common neurodegenerative disorder. Its annual cost in Europe in 2010 was around 14,000 million Euros, and its effect on the quality of life of patients and their families is incalculable (The Lancet 383; 1107-1109, 2014).
About the Author
Our website includes “Special Reports” and news, based on the latest biomedical and biotechnological research findings from the world’s top medical and scientific journals. A multidisciplinary editor staff gives a medical and personalistic bioethical assessment. It is also a dynamic means of communication with our readers to reflect on these issues.